This inventor holds 2 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 1 EPO patent. Top assignee: Sk Biopharmaceuticals Co., Ltd.. Active years: 2014-2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2014-2016
Title: Mi Jung Lim: Innovator in Neurodegeneration Research
Introduction
Mi Jung Lim is a prominent inventor based in Daejeon, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the area of neurodegeneration. With a total of two patents to his name, Lim's work focuses on innovative solutions for treating diseases related to neuronal apoptosis.
Latest Patents
Lim's latest patents include a pharmaceutical composition designed to inhibit apoptosis of neurons or neurodegeneration. This composition effectively prevents or treats diseases associated with neuronal apoptosis, showcasing Lim's commitment to advancing medical science and improving patient outcomes.
Career Highlights
Lim is currently associated with SK Biopharmaceuticals Co., Ltd., a company known for its dedication to developing innovative therapies. His work at the company has positioned him as a key player in the pharmaceutical industry, particularly in the realm of neurodegenerative diseases.
Collaborations
Some of Lim's notable coworkers include Cheol Hyoung Park and Hye Kyung Min, who contribute to the collaborative efforts in research and development within the company.
Conclusion
Mi Jung Lim's contributions to the field of neurodegeneration through his innovative patents and work at SK Biopharmaceuticals Co., Ltd. highlight his role as a significant inventor in the pharmaceutical industry. His research continues to pave the way for advancements in treating critical neurological conditions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile